Join
Live feed
·
PRReleasevia Quantisnow
Charles River Laboratories International Inc. logo

Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City

ByQuantisnow·Wall Street's wire, on your screen.
CRL· Charles River Laboratories International Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRL (Charles River Laboratories International Inc.) and more on Quantisnow.